Cargando…
Single-center Haemodialysis Experience in India During COVID-19
INTRODUCTION: Since COVID-19 has been announced as a pandemic, outcome of dialysis patients in terms of morbidity and mortality from India is lacking. We studied the clinical, epidemiological features of COVID-19 along with outcome in terms of mortality in our dialysis cohort. METHODS: Data of End-S...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121719/ https://www.ncbi.nlm.nih.gov/pubmed/35603111 http://dx.doi.org/10.4103/ijn.IJN_230_20 |
_version_ | 1784711212254101504 |
---|---|
author | Mahapatra, Himansu Sekhar Balakrishnan, Muthukumar Purusunani, Lalit Kumar, Adarsh Binoy, Renju Singh, Mansi Gautam, Abhisek Inamdar, Neeraj |
author_facet | Mahapatra, Himansu Sekhar Balakrishnan, Muthukumar Purusunani, Lalit Kumar, Adarsh Binoy, Renju Singh, Mansi Gautam, Abhisek Inamdar, Neeraj |
author_sort | Mahapatra, Himansu Sekhar |
collection | PubMed |
description | INTRODUCTION: Since COVID-19 has been announced as a pandemic, outcome of dialysis patients in terms of morbidity and mortality from India is lacking. We studied the clinical, epidemiological features of COVID-19 along with outcome in terms of mortality in our dialysis cohort. METHODS: Data of End-Stage Kidney Disease (ESKD) patients who were admitted in COVID-19 designated hospital block as positive and suspected patients from 1(st) April 2020 to 31(st) July 2020 was retrieved. Data about epidemiological characteristics, clinical features, mortality outcomes of COVID-19 positive and negative patients were analyzed. RESULTS: A total of 97 ESKD patients were admitted during the study period, of which 44 (45.4%) and 53 (54.6%) patients were found to be COVID-19 positive and negative respectively. The mean age of COVID positive patients was 46 years with 54.5% being female. Only three patients (6.8%) remained asymptomatic throughout the course of illness. Amongst COVID-19 positive, 20 (45.45%) were severely ill while 18 (40.9%) were having mild illnesses. Breathlessness (65.9%) and fever (61.4%) were common symptoms. The death occurred in 17 (38.6%) and 25 (47.1%) COVID-19 positive and negative ESKD patients respectively. 14 (82.3%) patients who expired amongst COVID-19 positive were having severe illness and significantly more were associated with negligible residual renal function. CONCLUSIONS: Breathlessness and fever were common symptoms amongst COVID-19 ESKD patients. Very few patients remained asymptomatic in our cohort and significantly more mortality is observed in severely ill patients and those with negligible residual renal function. |
format | Online Article Text |
id | pubmed-9121719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-91217192022-05-21 Single-center Haemodialysis Experience in India During COVID-19 Mahapatra, Himansu Sekhar Balakrishnan, Muthukumar Purusunani, Lalit Kumar, Adarsh Binoy, Renju Singh, Mansi Gautam, Abhisek Inamdar, Neeraj Indian J Nephrol Original Article INTRODUCTION: Since COVID-19 has been announced as a pandemic, outcome of dialysis patients in terms of morbidity and mortality from India is lacking. We studied the clinical, epidemiological features of COVID-19 along with outcome in terms of mortality in our dialysis cohort. METHODS: Data of End-Stage Kidney Disease (ESKD) patients who were admitted in COVID-19 designated hospital block as positive and suspected patients from 1(st) April 2020 to 31(st) July 2020 was retrieved. Data about epidemiological characteristics, clinical features, mortality outcomes of COVID-19 positive and negative patients were analyzed. RESULTS: A total of 97 ESKD patients were admitted during the study period, of which 44 (45.4%) and 53 (54.6%) patients were found to be COVID-19 positive and negative respectively. The mean age of COVID positive patients was 46 years with 54.5% being female. Only three patients (6.8%) remained asymptomatic throughout the course of illness. Amongst COVID-19 positive, 20 (45.45%) were severely ill while 18 (40.9%) were having mild illnesses. Breathlessness (65.9%) and fever (61.4%) were common symptoms. The death occurred in 17 (38.6%) and 25 (47.1%) COVID-19 positive and negative ESKD patients respectively. 14 (82.3%) patients who expired amongst COVID-19 positive were having severe illness and significantly more were associated with negligible residual renal function. CONCLUSIONS: Breathlessness and fever were common symptoms amongst COVID-19 ESKD patients. Very few patients remained asymptomatic in our cohort and significantly more mortality is observed in severely ill patients and those with negligible residual renal function. Wolters Kluwer - Medknow 2022 2022-01-05 /pmc/articles/PMC9121719/ /pubmed/35603111 http://dx.doi.org/10.4103/ijn.IJN_230_20 Text en Copyright: © 2022 Indian Journal of Nephrology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Mahapatra, Himansu Sekhar Balakrishnan, Muthukumar Purusunani, Lalit Kumar, Adarsh Binoy, Renju Singh, Mansi Gautam, Abhisek Inamdar, Neeraj Single-center Haemodialysis Experience in India During COVID-19 |
title | Single-center Haemodialysis Experience in India During COVID-19 |
title_full | Single-center Haemodialysis Experience in India During COVID-19 |
title_fullStr | Single-center Haemodialysis Experience in India During COVID-19 |
title_full_unstemmed | Single-center Haemodialysis Experience in India During COVID-19 |
title_short | Single-center Haemodialysis Experience in India During COVID-19 |
title_sort | single-center haemodialysis experience in india during covid-19 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121719/ https://www.ncbi.nlm.nih.gov/pubmed/35603111 http://dx.doi.org/10.4103/ijn.IJN_230_20 |
work_keys_str_mv | AT mahapatrahimansusekhar singlecenterhaemodialysisexperienceinindiaduringcovid19 AT balakrishnanmuthukumar singlecenterhaemodialysisexperienceinindiaduringcovid19 AT purusunanilalit singlecenterhaemodialysisexperienceinindiaduringcovid19 AT kumaradarsh singlecenterhaemodialysisexperienceinindiaduringcovid19 AT binoyrenju singlecenterhaemodialysisexperienceinindiaduringcovid19 AT singhmansi singlecenterhaemodialysisexperienceinindiaduringcovid19 AT gautamabhisek singlecenterhaemodialysisexperienceinindiaduringcovid19 AT inamdarneeraj singlecenterhaemodialysisexperienceinindiaduringcovid19 |